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Abstract
Background—The quality of pharmacologic care provided to older adults is less than optimal.
Medication therapy management (MTM) programs delivered to older adults in the ambulatory
care setting may improve the quality of medication use for these individuals.
Objectives—We conducted focus groups with older adults and primary care physicians to
explore: (1) older adults' experiences working with a clinical pharmacist in managing medications,
(2) physician perspectives on the role of clinical pharmacists in facilitating medication
management, and (3) key attributes of an effective MTM program and potential barriers from both
patient and provider perspectives.
Methods—Five focus groups (4 with older adults, 1 with primary care physicians) were
conducted by a trained moderator using a semi-structured interview guide. Each participant
completed a demographic questionnaire. Sessions were recorded, transcribed verbatim, and
analyzed using qualitative analysis software for theme identification.
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Results—Twenty-eight older adults and 8 physicians participated. Older adults valued the
professional, trusting nature of their interactions with the pharmacist. They found the clinical
pharmacist to be a useful resource, thorough, personable, and a valuable team member. Physicians
believe the clinical pharmacist fills a unique role as a specialized practitioner, contributing
meaningfully to patient care. Physicians emphasized the importance of effective communication,
pharmacist's access to the medical record, and a mutually-trusting relationship as key attributes of
a program. Potential barriers to an effective program include poor communication and lack of
familiarity with the patient's history. The lack of a sustainable reimbursement model was cited as a
barrier to widespread implementation of MTM.
Conclusions—This study provides information to assist pharmacists in designing MTM
programs in the ambulatory setting. Key attributes of an effective program include one that is
comprehensive, addressing all medication-related needs over time. The clinical pharmacist's
ability to build trusting relationships with both patients and providers is essential.
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INTRODUCTION
The overuse, underuse, and misuse of medications contribute to the sub-optimal quality of
care delivered to Americans.1–3 Older adults are at increased risk for poor quality of
medication use because multiple medications are often required for numerous chronic
diseases and are prescribed in an uncoordinated fashion by multiple providers.4–6 The poor
quality of medication use may account for almost 75% of all hospitalizations by older adults
in the United States.7,8 Thus, the health and well-being of older adults in the United States
relies on the appropriate prescribing of medications by health care providers as well as the
proper use and management of medications by patients.
The quality of medication use has been shown to be improved through outpatient
management that emphasizes appropriate medication use.9,10 However, to be effective,
health information must be shared and care must be coordinated among all providers and
patients.11 The federal government has recognized significant deficiencies in the care
delivered to older adults regarding medication use and has begun to align payment
incentives for pharmacists and others to provide medication therapy management (MTM) to
Medicare beneficiaries.12 Although MTM programs represent a promising approach to
reducing medication-related morbidity, mortality and unnecessary health care utilization,
studies are needed to identify the most effective and feasible models for delivering MTM
services.9,13,14 In particular, MTM programs offered in the ambulatory setting will be
critical to the development of the collaborative patient-centered medical home (PCMH). To
this end, we conducted a qualitative study to gain insights into the design and feasibility of
medication management services offered by clinical pharmacists from patients and primary
care physicians. These data will be used to design and evaluate an MTM program for older
adults receiving care within a physician-based outpatient clinic.
Objectives
We conducted focus groups with older adults and primary care physicians to explore: (1)
older adults' experiences working with a clinical pharmacist in managing their multiple
medications, (2) physician perspectives on the role of clinical pharmacists in facilitating
medication management, and (3) key attributes of an effective MTM program and potential
barriers from the perspective of both patients and providers.
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Overview of Study Design
Qualitative methods were chosen for their utility in exploring the topic from the perspective
of older adults and physicians, garnering richer data than quantitative methods may yield.15
Focus groups allow researchers to derive information through communication between
participants as well as allow for flexibility in exploring issues and still maintain internal
study validity.15 Thus, we conducted 5 focus groups: 4 with older adults and 1 with primary
care physicians. Our goal was to recruit 8–12 participants for each group, which is ideal for
generating discussion and allowing all participants sufficient opportunity to speak.16,17 The
number of focus groups was determined a priori for both patient and physician groups.
Study investigators felt that saturation would likely be reached after approximately 4
sessions with older adults and obtaining feedback from at least 1 group of physicians would
be sufficient to meet our needs for the purpose of designing an initial intervention. This
study was approved by the University of North Carolina at Chapel Hill Institutional Review
Board.
Participants
Older adults were eligible for the study if they were aged ≥ 60 years; taking ≥ 5 prescribed
medications; residing independently in Orange County, NC; responsible for managing their
own medications (without reliance on a caregiver or family member); and either of white or
black race.
Physicians were eligible if they practiced in an outpatient setting in Orange County, NC;
provided care to individuals ≥ 60 years of age; and had experience working with a clinical
pharmacist. We felt that the design of the MTM program would best be informed by
physicians who had experience working with pharmacists in such a program.
Recruitment and Enrollment
Older Adults—We identified a convenience sample of older adults from a registry of
patients enrolled in the Eldercare Program through the Orange County Department on Aging
and two senior housing facilities located in Chapel Hill, NC.18 The Eldercare Program
provides social services and case management to nearly 300 older persons residing
independently in their own homes, apartments, or senior housing. Both senior housing
complexes are affiliated with the Eldercare Program. We purposively sampled older adults
with mixed degrees of exposure to clinical pharmacist services to ensure that we were
reaching a wide audience, which ranged from those having episodic encounters with a
clinical pharmacist to those receiving continuous care with an ongoing relationship with the
clinical pharmacist. Participants were contacted by a pharmacist using a telephone script
until 8–12 eligible older adults were reached who expressed an interest in participating.
Physicians—We purposively sampled physicians in Orange County from diverse
outpatient clinic settings (e.g., academic medical center ambulatory care clinics, geriatric
specialty outpatient clinics, community-based private physician clinics, family medicine
clinics, federally qualified health programs) until 8 eligible physicians were reached who
expressed an interest in participating.
Focus Group Methodology
Four focus groups with older adults were held between October and December 2008 at a
local senior center; one focus group with physicians was held in February 2009 at the UNC
Eshelman School of Pharmacy. All focus groups were approximately 90 minutes. Prior to
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each session, participants completed informed consent and a demographic questionnaire.
Each session was moderated by a trained, experienced qualitative researcher (MV) to
minimize bias and ensure that all participants were provided an opportunity to speak and
provide input. In addition, all sessions were recorded using a digital voice recorder. To
maintain consistency, the same moderator conducted all focus groups using a semi-
structured interview guide developed by the investigators (Appendix); one interview guide
for the older adult group, one for the physician group. Both focused on the same study
objectives, but were tailored to the audience.
In the older adult groups, the discussion focused on 1) older adults' experiences managing
their multiple medications, specifically as it related to working with a clinical pharmacist in
managing their multiple medications and 2) gathering feedback from older adults on a
proposed MTM program. Participants received a $30 honorarium, light snacks during the
focus group discussion, and the opportunity for a free medication review with a clinical
pharmacist following the session. In the physician group, the discussion focused on 1)
experiences working collaboratively with clinical pharmacists in the outpatient, ambulatory
setting, and 2) obtaining physician input into a proposed MTM program for older adults.
Each physician received a $100 honorarium and dinner during the focus group discussion.
At the start of each focus group session, the moderator introduced the study, briefly
explained the objectives of the session, and opened the session with an icebreaker. In all
groups, participants were encouraged to respond to any issues raised by the moderator but
were not forced to respond. The moderator sought to engage all participants, avoid the
discussion being dominated by a single individual, and minimize interjection.
Data Collection and Analysis
All focus groups were audio-taped, transcribed verbatim, and analyzed using Atlas Ti
qualitative data analysis software to identify themes through a Natural Language Processing
method.16,17 The data collection and analysis was conducted by a trained, independent,
qualitative researcher (MV). Group-to-group validation was performed to yield consistent
themes in the groups.15,19
Once the data were analyzed, 3 investigators (JL, MV, MR) also reviewed the focus group
findings several times to consolidate observations into a common set of themes, which were
then agreed upon by the investigators. Disagreement was resolved through re-reading the
transcripts together; using these multiple methods and investigators helps to avoid
perception and blind interpretive bias. Key words and phrases were identified that provided
descriptive information to support each theme. Verbatim quotations were identified that
supported or further elaborated on an identified theme. Descriptive statistics were calculated
for all variables collected as part of the demographic questionnaire.
RESULTS
Twenty eight older adults (Table 1) and 8 physicians (Table 2) participated in the focus
groups. The findings from the focus groups are summarized according to the studies primary
objectives: (1) older adults' experiences working with a clinical pharmacist in managing
their multiple medications, (2) physician perspectives on the role of clinical pharmacists in
facilitating medication management, and (3) key attributes of an effective MTM program
and potential barriers from the perspective of both older adults and providers. Table 3
provides an outline of each of the three objectives along with the emerging themes and
supporting key words and phrases.
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Older Adults' Experience Working with a Clinical Pharmacist
Older adults valued the professional nature of their interactions with clinical pharmacists.
They found that the clinical pharmacist was a useful resource, with a wealth of knowledge
about medications, including benefits of the medication, proper use, side effects, and drug
interactions. They found the clinical pharmacist valuable, accessible, approachable, and
personable. One participant referred to her clinical pharmacist as “really at the top of her
game. She knows her stuff and is easy to get along with.” They spoke, too, about the
comprehensive nature of the interaction with clinical pharmacists, the time spent with them,
the follow-up provided, and the attention given to their medications, which is “largely not
available when interacting with a pharmacist in the community pharmacy setting.” One
patient stated “She has the knowledge and understands your overall health and knows the
finer points.” Older adult participants also felt that there were qualities in the clinical
pharmacist that were different from, yet complementary to, their physician. Patients spoke
about the clinical pharmacist complementing the medical care provided by the physicians,
their ability to work well with their physicians and talk to them frequently. According to one
patient, “Doctors are so busy, I don't think there is often time for that personal relationship.
They open up a pill bottle and ask you how are things going and you say “ok.'”
Physician Perspectives on the Role of Clinical Pharmacists in Facilitating Medication
Management
Physicians in particular felt that the clinical pharmacist fills a unique role as a specialized,
mid-level practitioner who enhances the connection with older patients around medication
use. They cited a “personality” that feels comfortable talking to patients and providers alike.
The positive attributes of a clinical pharmacist as characterized by physicians include: 1) the
ability of pharmacists to see patients for targeted visits in between physician visits, 2) the
time they are able to spend talking with the patients about their medications, 3) their
excellent communication skills, and 4) their personality and approach to interacting with the
patients. Specific physician comments supporting the above statements include:
“With diabetes management and care, I can schedule interval visits and if my
schedule is full, I can have them come back in two weeks or three weeks and see
the clinical pharmacist, get very specific instructions about diabetes management
and then follow up with me in six weeks or eight weeks and so it's great for an
interval visit with a very specific goals for that visit.”
“I see the clinical pharmacist as having a special niche. Because of their detailed
oriented training and medication management, they're much more fluent and
immediately feel more comfortable with medicines. They can always come to me
and so I think they fill a niche in our very complicated population…”
“There is a need to build a relationship of mutual trust between the clinical
pharmacist and the physician so that the clinical pharmacist can understand the
goals and approaches to treatment and the physician can have some knowledge of
the clinical pharmacist's skills. I think that the more the program is sort of home
based, the more interactions between the two, the more it can be effective.”
“Our patients have an excellent relationship with the clinical pharmacist that runs
the medication management clinic and I'm not so sure it's the position of clinical
pharmacist. I really think personality, trust, and the personal interaction with the
patients is kind of what is winning them over. I do think that other people in that
position might not have the same level of success….it's a combination of the right
personality and competence that wins them over and they look forward to seeing
her…I think communication has been the key making that relationship a productive
one.”
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Physicians also noted potential areas of concern that they have encountered throughout the
years when working with pharmacists. These include pharmacists who: 1) make
recommendations when unfamiliar with the patient's history, 2) do not have access to or
review the patient's medical record, 3) make medical and diagnostic assessments, 4) have an
undefined role on a team or in the care of the patient, and 5) have poor communication with
the physician.
“Sometimes I think the nuances of providing clinical care with multiple
medications benefit from someone who has known that patient for a long time,
knows their habits and ability to follow a particular regimen over a period of time
and perhaps can see the bigger picture as to where we are going. Sometimes elderly
patients with other co-morbidities, I'm not focused on that same A1C…There are
also some patients that I know are going to be non-adherent so my goals are little
bit different for them and sometimes it's frustrating for them to interact with the
pharmacist who is not aware of these goals and it's also frustrating for the
pharmacist to interact with the patients.”
“The interaction is only effective if medical records are viewed first…that's what
co-management, collaboration is about. That's where the two-way street happens,
the relationship because that is how trust is built…because you are on the same
page.”
Key Attributes of an Effective MTM Program and Potential Barriers from the Perspective of
Patients and Providers
Older adult participants identified the following as key attributes for the research team to
consider in designing and implementing a medication management service:
• Team effort and trust: having a doctor and clinical pharmacist work together in a
team effort on their behalf, entrusting all to do their part
• Personalized care: having a personal pharmacist – someone to assist with tasks
such as reducing unnecessary medications, preparing a written list of all
medications, or organizing the medications that need to be taken.
• Comprehensive: providing thorough medication reviews to assess effectiveness and
safety; facilitating prescription refills; providing education around chronic care
management and medications; assisting with Medicare Part D prescription drug
plans.
Participants identified some of the potential problems with this type of program, including
the availability of a pharmacist who would be willing to carry out such responsibilities and a
perceived lack of need, in some patients, for any additional assistance with medication
management. The issue of “cost to receive the service” was also a main concern for this
program. While participants agreed it was a valuable service that they would be willing to
pay for, the amount would have to be within their means. Participants suggested a “one-time
payment for services in the format similar to insurance so that you can access the clinical
pharmacist when needed, for as long as you need, with whatever you need.”
Physician participants identified the following as key attributes for the research team to
consider in designing and implementing a medication management service:
• A trusting relationship: the need to build a relationship of mutual trust between the
clinical pharmacist and the physician so that the clinical pharmacist can understand
the goals and approaches to treatment, the physician can be assured of the clinical
pharmacist's knowledge and skills, and the benefit to the patient is maximized.
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• Communication and collaboration: effective communication and interaction
between the clinical pharmacist and the physician; direct face-to-face interaction is
key, not emails and faxes
• Patient-centered: clinical pharmacists must understand the social nuances of care
and the people with whom they are interacting; medical records should be reviewed
and time should be spent with the patient.
• Value-added: an effective MTM program should make the physician a better
doctor. While physicians know some things about pharmacy, their interactions with
clinical pharmacists should help them learn more. It should be a “value added”
exchange so that physicians will be better equipped when treating other patients.
• Comprehensive: medication management should involve more than a medication
review, with quality time spent, adequate follow-up, and medication reconciliation
provided at the point of care transitions.
• Targeted: targeting certain populations, such as those with lower socioeconomic
status, high comorbidity burden, and complex regimens are important
considerations in designing a program.
Physicians identified some potential barriers to an effective program that should be
considered when designing and implementing the service, including receiving too many
recommendations, stating that “recommendations should be short and focused on priorities
so that you don't overwhelm the receiver and hopefully have the highest chance of initiating
some change”. In addition, poor communication and providing services to those who may
not need it were cited as potential barriers to successful implementation. Finally, payment
for the services provided by clinical pharmacists was felt to be a significant barrier to
widespread uptake and success. Physicians felt that a long-term, sustainable approach,
beyond a fee-for-service model, is needed.
DISCUSSION
This study provides useful information from older adults and physicians regarding the
defining characteristics of a clinical pharmacist and key attributes of an effective MTM
program as well as potential barriers that must be considered in designing and implementing
a program.
In summary, older adults reported that MTM services were valuable and meaningfully
impacted their ability to manage medications. They specifically appreciated clinical
pharmacists discontinuing unnecessary medications, providing a written list of medications,
assisting with Medicare Part D prescription drug plan selection, and facilitating
communication with their physicians. The physicians suggested that frequent and effective
communication between the clinical pharmacist and physician is essential and that the
program would be most effective when the number of recommendations are short and
focused. In addition, physicians felt that the program would be most effective when
pharmacists take the time to review the medical record and get to know the patients. It was
felt that the program could be tailored or targeted to at-risk patients, including those on
multiple medications or with multiple comorbidities. Older adults and physicians alike
expressed the importance of building a trusting, professional relationship.
As has been reported in previous research, the absence of face-to-face communication and
collaboration and “a trusting relationship” were viewed as potential barriers to successful
implementation of an MTM program.20 Communication is critical to improving health
outcomes; in addition, a trusting relationship is at the heart of the patient-physician-
pharmacist relationship.21,22
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Payment for clinical pharmacist's services was viewed as a potential barrier to widespread
uptake. Despite the implementation of an MTM program in 2006 through Medicare Part D
prescription drug plans and alignment of payment incentives this program continues to reach
a minority of Medicare beneficiaries in need; is primarily delivered telephonically or via fax;
does not provide a sustainable business model; and has demonstrated minimal impact to
date.12,23 While some studies have demonstrated cost savings and improved outcomes with
clinical pharmacist-delivered MTM services in ambulatory care settings, widespread
reimbursement for such services is lacking.9,24 Bundled payments, where clinical
pharmacist services are incorporated as part of a medical team approach and payment
aligned to the team for the provision of high quality care is one potential approach to
building a sustainable business model for clinical pharmacist-delivered MTM services.
These qualitative findings highlight the need to consider older adult and physician
perspectives in the design of a MTM program.
Limitations
Our study had several limitations. First, although the size of our focus groups was typical (8
to 12 persons), our sample included 28 adults and 8 physicians in a specific region in North
Carolina, which limits generalizability. The number of focus groups was typical; however,
the number was determined a priori and not according to thematic saturation. The
participants in the study were recruited via a convenience sample from a registry, thus
limiting our reach to a more diverse population. However, the participants represented a
variety of demographic characteristics and experience levels, thus we believe we captured a
range of perspectives. Finally, patients and physicians often had experience with only one or
two clinical pharmacists, which also may limit the generalizability of the findings. Future
research of this kind in North Carolina could include a broader composition of older adults
and physicians throughout various counties in the state.
CONCLUSIONS
This study provides information to assist pharmacists in designing MTM programs in the
ambulatory setting. Key attributes of an effective program include one that is
comprehensive, addressing all of the patients' medication-related needs over time. The
ability of the clinical pharmacist to build trusting relationships with both patients and
providers is essential.
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Appendix. A focus group study of medication management in older adults
discussion guide
Older Adults
Key Areas Facilitator questions
Introduction • One of the terms some people use when they talk about medication use is “Medication
management.” It may be a term that you may or may not have heard before. Now, if
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Key Areas Facilitator questions
someone were to talk to you about how you “manage your medications,” what does this
mean to you?
Key Questions • For those of you have interacted with a clinical pharmacist tell me about this experience?
What did you like about the interaction and/or the service provided? How does he/she
help you with your medications?
• What do you think about having a clinical pharmacist sit down and review with you all of
your medications (prescriptions, herbals, over-the-counter meds) to learn how you are
taking them and to go over all of them with you?
• What about having a clinical pharmacist talk to your doctor about ways to improve your
medications to make them safer or more effective for you?
• What about meeting with a clinical pharmacist every time you had major changes made
to your medications to make sure they are still safe and effective for you?
• What about contacting a clinical pharmacist when you are confused about what you are
supposed to be doing or do not understand your medications or need him/her to help you
sort everything out?
• For those of you in the Medicare prescription drug program, what about meeting with a
clinical pharmacist every year to make sure you are in the best prescription plan for you?
What would you be willing to pay for this type of service?
Physicians
Key Areas Facilitator questions
Introduction • My understanding is that all of you have worked with a clinical pharmacist (to varying
degrees) in the outpatient setting to improve your elderly patients' medication use.
Describe your experience, including the type of services provided by the clinical
pharmacist in the outpatient, ambulatory care setting.
Key Questions • What did you like about the interactions or services provided? What worked well?
• What did you not like, or what could have been done differently to improve your
interactions with the clinical pharmacist?
• How do you think a medication management program that includes a comprehensive
medication review, assessment of patient's medication use and needs, providing proposed
recommendations to you, and personally calling the patient would be for yourself or other
physicians in primary care practice?
• What are some of the good things about this program?
• What might be some of the potential problems?
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Table 1
Demographics of Participants (N=28); Number (%)
Age, mean 77.7
Female, n (%) 23 (82)
Race, n (%)
 Whites 18 (64)
 Blacks 10 (36)
Highest level of education, n (%)
 Elementary/technical school 2 (7)
 Some high school 5 (18)
 High school graduate 7 (25)
 Some college 5 (18)
 College graduate 6 (21)
 Postgraduate work 3 (11)
Lives alone, n (%) 19 (68)
Number of physicians, n (%)
 1 4 (14)
 2 to 5 19 (68)
 5 or more 5 (18)
Number of medications, n (%)
 5 or less 6 (21)
 6–10 10 (36)
 11–15 6 (21)
 16–20 6 (21)
Type of prescription insurance, n (%)*
 Medicaid 3 (11)
 Medicare Part D 16 (57)
 Private insurance 16 (57)
 Veterans Affairs benefits 3 (11)
 Hospital benefits program 1 (4)
 No coverage 1 (4)
*
May not add to 100% because participants could report more than one type of insurance
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Table 2
Demographics of Physicians (N=8); Number (%)
Years in practice, average 18 (range 5–33)
Male, n (%) 6 (75)
Specialty training*
 Geriatrics 4 (50)
 Internal Medicine 6 (75)
 Family Medicine 1 (13)
Time spent in outpatient care (%)
 ≤ 10% 0
 11–25% 1 (13)
 26–49% 2 (25)
 50–75% 4 (50)
 >75% 1 (13)
Patients seen by physician who are 65 years of age or older (%)
 ≤ 10% 1 (13)
 11–25% 0
 26–49% 1 (13)
 50–75% 3 (38)
 >75% 3 (38)
*
May not add to 100% because physicians could report more than one area of specialty training
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Table 3
Emergent themes and key words and phrases for designing an effective medication management program
Study objective Themes and supporting key words and phrases
Explore older adults'
experiences working with

















Themes: Professional, competent thorouah
• Specialized, mid-level practitioner
• Provides interval visits
• Spends more time with patients
• Has a special niche
• Possesses excellent communication skills
• Approaches patient interaction with a certain personality






Themes: Team-based, personalized care,
comprehensive
• Establish team effort and trust
• Develop personal relationship with
the pharmacist
• Provide personalized care
• Review medications and determines
effectiveness
• Refill prescriptions
• Intercede with health plans
• Facilitate care during trips
• Maintain contact with family
Physicians
Themes: Trustina relationship, effective communication,
comprehensive
• Develop mutual relationship of trust
• Interact directly with providers
• Provide patient-centered care and value-added
services
• Develop familiarity with patient history
• Conduct a comprehensive service – more than
a medication review
• Target specific populations (including lower
socioeconomic status, high co-morbidities,
complex regimens)
Explore potential barriers
from the perspective of
Themes: Perceived need, cost of service
• Perceived lack of need for additional
assistance
• Out-of-pocket costs
• Availability of a pharmacist
Themes: Target population, poor communication, unclear
service model
• Receiving too many and unfocused
recommendations
• Make inappropriate medical assessments
• Access to the medical record
• Undefined role on the patient care team
• Poor communication
• Providing services to untargeted populations
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Study objective Themes and supporting key words and phrases
both patients and
providers
• Inconvenient payment structure for
services
• Uncertain payment for services
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